Date:
Day1:


ET
Day2:


ET

The U.S. Food and Drug Administration (FDA) in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) will host a two-day virtual public workshop entitled, “Topical Drug Development – Evolution of Science and Regulatory Policy 2” on July 23-24, 2020. This workshop will bring together stakeholders from the FDA, academia, and industry to discuss recent advances in the assessment of dermal absorption using in vivo, in vitro, and in silico